NCT00470886已完成不适用
A Non-Interventional, Post-Marketing Surveillance, Phase IV Study to Assess Compliance With Antihypertensive Telmisartan Therapy
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Bayer
- 入组人数
- 3,400
- 主要终点
- Efficacy and safety of the treatment with telmisartan reported by the physician with regard to usage the HelpingHand device
研究概览
简要总结
The purpose of this study is to asses the efficacy and safety of Telmisartan depending on the use of an electronic therapy monitoring device (HelpingHand) in a real life setting and to asses patients compliance to the therapy with Telmisartan in relation to use of electronic therapy monitoring device.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age over 18
- •Untreated or ineffectively treated arterial hypertension
排除标准
- •Cholestatic disorders and severe hepatic failure
- •Allergy to Telmisartan
- •Pregnancy and lactation period
- •Unwillingness to participate in the study
- •Inability to use the drug reminder device
- •Unwillingness to use the drug reminder device
研究组 & 干预措施
Group 1
干预措施: Telmisartan (Kinzal/Pritor, BAY68-9291) (Drug)
结局指标
主要结局
Efficacy and safety of the treatment with telmisartan reported by the physician with regard to usage the HelpingHand device
时间窗: At all four planned control visits. (Approx. interval between visits 3 months)
次要结局
- Compliance with the treatment calculated on the basis of by HelpingHand and patients questionnaires(At all four planned control visits. (Approx. interval between visits 3 months))
研究者
相似试验
已完成
不适用
The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial HypertensionHypertensionNCT00471003Bayer5,448
已完成
不适用
Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With HypertensionHypertensionNCT02242838Boehringer Ingelheim6,336
已完成
不适用
Using Telmisartan Alone or Combination of Telmisartan -HCTZ in the Treatment of Mild to Moderate Essential HypertensionHypertensionNCT00638911Boehringer Ingelheim33,247
已完成
不适用
Post-marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ryzodeg®DiabetesNCT02821052Novo Nordisk A/S1,355
已完成
不适用
A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox CapsuleSchizophreniaBipolar DisorderNCT01053429Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3,391